Registration of the meeting of representatives of Novartis Slovakia s.r.o. with representatives of MZ SR, on 1.10.2015 at 10.00 am. at MZ SR

For MZ SR:

• director-General Department of Pharmacy and Drug Policy MUDr. Adam Hlôška

• director of the Department of Classification, Pricing and Drug Policy PharmDr. Rastislav Pullmann

• officer of the Department of Classification, Pricing and Drug Policy of MVDr. Erika Hanzelyová

For Novartis Slovakia s.r.o.:

• Marianthi Psava - CPO Head & Country President

• Mgr. Michal Tuma - Head of Market Access

• Magdaléna Petrova - Market Access Manager

The meeting was opened by the Director General of the Department of Pharmacy and Drug Policy Dr. Adam Hlôška.

MZ SR:

In this period, the Ministry sent letters to the drug registry holders for vaccines, in which it points out compliance with applicable legislation availability of medicines in Slovakia. Since the Ministry received official information on the change of the holder of the authorisation of vaccines from Novartis na GSK, interested in who currently holds the authorisation of these vaccines.

Novartis:

There is currently a transitional period during which all official matters between Novartis and GSK. Novartis will find out who is currently the official holder of the vaccine registration.

The sitting was closed by the Director-General of the Department of Pharmacy and Drug Policy Dr. Adam Hlôška.